S&P 500   5,088.80
DOW   39,131.53
QQQ   437.52
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Analysts boosted Snowflake stock, big firms are buying now
First it was Tyson stock, now this food company is set to rally
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
6 reasons to buy Teva Pharmaceuticals stock sooner than later
3 Chinese stocks poised for rebound
S&P 500   5,088.80
DOW   39,131.53
QQQ   437.52
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Analysts boosted Snowflake stock, big firms are buying now
First it was Tyson stock, now this food company is set to rally
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
6 reasons to buy Teva Pharmaceuticals stock sooner than later
3 Chinese stocks poised for rebound
S&P 500   5,088.80
DOW   39,131.53
QQQ   437.52
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Analysts boosted Snowflake stock, big firms are buying now
First it was Tyson stock, now this food company is set to rally
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
6 reasons to buy Teva Pharmaceuticals stock sooner than later
3 Chinese stocks poised for rebound
S&P 500   5,088.80
DOW   39,131.53
QQQ   437.52
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Analysts boosted Snowflake stock, big firms are buying now
First it was Tyson stock, now this food company is set to rally
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
6 reasons to buy Teva Pharmaceuticals stock sooner than later
3 Chinese stocks poised for rebound

Molecular Partners (MOLN) Earnings Date, Estimates & Call Transcripts

$4.01
-0.39 (-8.86%)
(As of 02/23/2024 06:55 PM ET)
Skip Charts & View Estimated and Actual Earnings Data

MOLN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MOLN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Molecular Partners Analyst EPS Estimates

Current Year EPS Consensus Estimate:($2.10) EPS
Next Year EPS Consensus Estimate: ($2.11) EPS

MOLN Earnings Date and Information

Molecular Partners has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 14th, 2024 based off prior year's report dates.

Molecular Partners Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/14/2024
Estimated)
------- 
10/26/2023Q3 2023-($0.40)($0.40)($0.40)-$2.88 million
8/23/2023Q2 2023-($0.55)($0.55)($0.55)-$0.46 million
5/12/2023Q1 2023-($0.49)($0.49)($0.49)-$3.30 million
3/9/2023Q4 2022-($0.56)($0.56)($0.56)-$2.80 million
10/27/2022Q3 2022-($0.42)($0.42)($0.42)-$2.45 million
8/25/2022Q2 2022-($0.15)($0.15)($0.15)-$12.19 million    
5/12/2022Q1 2022-$5.00+$5.00$5.00-$187.07 million
3/15/2022Q4 2021-($0.61)($0.61)($0.61)-$1.96 million
10/28/2021Q3 2021($0.55)($0.41)+$0.14($0.41)$2.00 million$3.85 million












Molecular Partners Earnings - Frequently Asked Questions

When is Molecular Partners's earnings date?

Molecular Partners has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 14th, 2024 based off last year's report dates. Learn more on MOLN's earnings history.

How much revenue does Molecular Partners generate each year?

Molecular Partners (NASDAQ:MOLN) has a recorded annual revenue of $198.70 million.

How much profit does Molecular Partners generate each year?

Molecular Partners (NASDAQ:MOLN) has a recorded net income of $123.50 million. MOLN has generated -$2.00 earnings per share over the last four quarters.

What is Molecular Partners's EPS forecast for next year?

Molecular Partners's earnings are expected to decrease from ($2.10) per share to ($2.11) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:MOLN) was last updated on 2/26/2024 by MarketBeat.com Staff